| 1C5M | F: | STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
| 1EZQ | B: | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515 |
| 1F0R | B: | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815 |
| 1F0S | B: | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707 |
| 1FAX | L: | COAGULATION FACTOR XA INHIBITOR COMPLEX |
| 1FJS | L: | CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA |
| 1G2L | B: | FACTOR XA INHIBITOR COMPLEX |
| 1G2M | B: | FACTOR XA INHIBITOR COMPLEX |
| 1HCG | B: | STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 ANGSTROMS RESOLUTION |
| 1IOE | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55532 |
| 1IQE | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55590 |
| 1IQF | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55165 |
| 1IQG | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55159 |
| 1IQH | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55143 |
| 1IQI | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55125 |
| 1IQJ | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55124 |
| 1IQK | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55113 |
| 1IQL | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54476 |
| 1IQM | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54471 |
| 1IQN | L: | HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55192 |
| 1KSN | B: | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH FXV673 |
| 1LPG | A: | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79. |
| 1LPK | A: | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125. |
| 1LPZ | A: | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41. |
| 1LQD | A: | CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45. |
| 1MQ5 | L: | CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL) AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA |
| 1MQ6 | L: | CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2-PYRIDINYL) AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-OXAZOLYL) METHYLAMINO]METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA |
| 1NFU | B: | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747 |
| 1NFW | B: | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685 |
| 1NFX | B: | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944 |
| 1NFY | B: | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095 |
| 1P0S | L:87-138 | CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEX WITH ECOTIN M84R |
| 1V3X | B: | FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE |
| 1WU1 | B: | FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5-CHLOROINDOL-2-YL) SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE |
| 1XKA | L:49-86; L:87-139 | FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID |
| 1XKB | A:48-86; A:87-138; B:50-86; B:87-139 | FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID |
| 2BOH | A: | CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND "1" |
| 2CJI | B: | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2D1J | B: | FACTOR XA IN COMPLEX WITH THE INHIBITOR 2-[[4-[(5-CHLOROINDOL-2-YL)SULFONYL]PIPERAZIN-1-YL] CARBONYL]THIENO[3,2-B]PYRIDINE N-OXIDE |
| 2EI6 | B: | FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-CIS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE |
| 2EI7 | B: | FACTOR XA IN COMPLEX WITH THE INHIBITOR TRANS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE |
| 2EI8 | B: | FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-4-(N,N-DIMETHYLCARBAMOYL)-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL) CARBONYL]-1,2-CYCLOHEXANEDIAMINE |
| 2GD4 | A:87-138; L:87-138 | CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX |
| 2H9E | L:89-136 | CRYSTAL STRUCTURE OF FXA/SELECTIDE/NAPC2 TERNARY COMPLEX |
| 2J2U | B: | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J34 | B: | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J38 | B: | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J4I | B: | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J94 | B: | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2J95 | B: | CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
| 2P3F | L: | CRYSTAL STRUCTURE OF THE FACTOR XA/NAP5 COMPLEX |
| 2PHB | B: | AN ORALLY EFFICACIOUS FACTOR XA INHIBITOR |
| 2PR3 | B: | FACTOR XA INHIBITOR |
| 2RA0 | L: | X-RAY STRUCTURE OF FXA IN COMPLEX WITH 7-FLUOROINDAZOLE |
| 2UWL | B: | SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA |
| 2UWO | B: | SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA |
| 2UWP | B: | FACTOR XA INHIBITOR COMPLEX |
| 2VH0 | B: | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS |
| 2VH6 | B: | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS |
| 2WYG | B: | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS |
| 2WYJ | B: | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS |
| 2Y7X | B: | THE DISCOVERY OF POTENT AND LONG-ACTING ORAL FACTOR XA INHIBITORS WITH TETRAHYDROISOQUINOLINE AND BENZAZEPINE P4 MOTIFS |
| 2Y7Z | B: | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS |
| 2Y80 | B: | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS |
| 2Y81 | B: | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS |
| 2Y82 | B: | STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS |
| 3IIT | B: | FACTOR XA IN COMPLEX WITH A CIS-1,2-DIAMINOCYCLOHEXANE DERIVATIVE |
| 3KL6 | B: | DISCOVERY OF TETRAHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVE TAK-442: A POTENT, SELECTIVE AND ORALLY ACTIVE FACTOR XA INHIBITOR |
| 3LIW | B: | FACTOR XA IN COMPLEX WITH (R)-2-(1-ADAMANTYLCARBAMOYLAMINO)-3-(3-CARBAMIDOYL-PHENYL)-N-PHENETHYL-PROPIONIC ACID AMIDE |
| 3Q3K | B: | FACTOR XA IN COMPLEX WITH A PHENYLENEDIAMINE DERIVATIVE |
| 3TK5 | B: | FACTOR XA IN COMPLEX WITH D102-4380 |
| 3TK6 | B: | FACTOR XA IN COMPLEX WITH D46-5241 |
| 4A7I | A: | FACTOR XA IN COMPLEX WITH A POTENT 2-AMINO-ETHANE SULFONAMIDE INHIBITOR |
| 4BTI | A:; E: | FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 58. |
| 4BTT | A:; E: | FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 31. |
| 4BTU | A:; E: | FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 57. |
)
)